According to a survey conducted in 2024, 35 percent of surveyed biopharma executives stated that the usage of the functional service provider (FSP) outsourcing model has increased compared to two years ago. This statistic describes the change in full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024.
Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024
Respondents from large companies: n=64, from small/mid: n=86
Method of interview
Panel survey
Supplementary notes
The respondents are working for pharma, biopharma, or
biotech companies; they have drug development decision-making responsibility and
are director-level or above; they work in a role related to drug development; their companies have at least one compound in development; they are from the US/Canada, Europe, and Asia.
Original question: "Over the past two years, how has your company changed its full-service clinical trial outsourcing behavior?"
"Over the past two years, how has your company changed its functional service provider (FSP) outsourcing behavior?"
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Thermo Fisher (PPD). (September 16, 2024). Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1414582/biopharmaceutical-outsourcing-models-change/
Thermo Fisher (PPD). "Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024." Chart. September 16, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1414582/biopharmaceutical-outsourcing-models-change/
Thermo Fisher (PPD). (2024). Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1414582/biopharmaceutical-outsourcing-models-change/
Thermo Fisher (PPD). "Change in Usage of Full-service and Fsp Outsourcing Models among Biopharmaceutical Companies Worldwide in 2022-2024." Statista, Statista Inc., 16 Sep 2024, https://www.statista.com/statistics/1414582/biopharmaceutical-outsourcing-models-change/
Thermo Fisher (PPD), Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024 Statista, https://www.statista.com/statistics/1414582/biopharmaceutical-outsourcing-models-change/ (last visited November 21, 2024)
Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2022-2024 [Graph], Thermo Fisher (PPD), September 16, 2024. [Online]. Available: https://www.statista.com/statistics/1414582/biopharmaceutical-outsourcing-models-change/
